Aktiesnakken — August 2012
-
Neuroserach.. når de nu har nedskrevet værdien på Huntington og fedme.. hvar har de så tilbage???
-
der er jo en fantastisk aftale. Omsætningsvæksten den skyldes daraalene i driften
-
så de får 65 mill om året for at køre den?
-
det synes jeg godt vi kan give en ekstra 1,5 krone for
-
alt under 80 skal købes mener jeg. Over 90 bør man nok tage PP
-
den starter i hvert fald i plus samuel
-
jeg mener 90 er ok
-
I skal også tænke længere
-
men ja den skal vel op omkring emissionskursen
-
hvis bare CLL frontline er positive er alt reddet for genmab
-
kurs 100 drenge
-
den starter jo ikke i 70. !!!!!!!!
-
den starter slet ikke under 80
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind